Related Experiment Video
Updated: Aug 13, 2026
07:13
Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts
Published on: May 13, 2014
Retinoic acid and its receptors
1Department of Pathology, Harbor-UCLA Medical Center, Torrance 90509.
American Journal of Surgery
|July 1, 1993
Summary
Retinoic acid (RA), a vitamin A metabolite, influences cell growth, development, and tumor inhibition but can be teratogenic. Its diverse effects are mediated by specific retinoic acid receptors, suggesting tailored therapeutic applications.
Area of Science:
- Biochemistry
- Developmental Biology
- Molecular Biology
Background:
- Retinoic acid (RA), the active form of vitamin A, exhibits wide-ranging effects on cellular processes.
- RA plays critical roles in embryonic development, cell differentiation, and proliferation.
- While RA shows promise in cancer therapy, its teratogenic potential necessitates careful consideration.
Purpose of the Study:
- To explore the multifaceted biological effects of retinoic acid and its analogues.
- To understand the mechanisms underlying RA's influence on growth, differentiation, and development.
- To highlight the potential clinical applications of retinoids in cancer treatment and prevention.
Main Methods:
- Characterization of retinoic acid receptors (RARs).
- Analysis of the biological activities of RA and its analogues.
- Investigation of RA's role in embryonic pattern formation and tumor growth inhibition.
Main Results:
- Retinoic acid demonstrates pleiotropic effects impacting growth, differentiation, proliferation, and development.
- RA is crucial for embryonic pattern formation and exhibits tumor growth inhibitory properties.
- RA has been successfully employed as a differentiation therapy for acute promyelocytic leukemia.
Conclusions:
- The diverse biological roles of retinoic acid are attributed to its interaction with specific retinoic acid receptors.
- Each characterized retinoic acid receptor appears to mediate distinct functions.
- Understanding these receptor-ligand interactions is key to leveraging retinoids for therapeutic benefit, particularly in oncology.
More Related Videos
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
05:03Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: